Please assess the completion status of the following clinical trial:

Trial Title: Evaluation of Inflammatory Symptoms Reduction With Amoxicillin + Ketoprofen in Acute Pharyngeal Tonsillitis in Pediatric Patients

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Quick-test positive for Streptococcus pyogenes;~* Indication for treatment with amoxicillin according to labeling and physician's clinical evaluation;~* Pain (for swallowing) evaluated by Wong Baker Faces Pain scale with at least grade 3;~* Presence of at least two of the follow symptoms:~  * Hyperemia and edema evaluated with at least 2 out of 4 crosses~ * Fever in the previous 48 hours~ * Cervical adenomegaly~ * Tonsilla with erythema or erythema and white exsudate.~Exclusion Criteria:~* History of cardiovascular, gastrointestinal, metabolic or psychiatric conditions;~* History and laboratorial confirmation of hematologic, hepatic or renal disorders;~* Use of nonsteroidal antiinflammatory drugs (NSAID) during the last 3 weeks and gastroesophageal reflux during the last 6 months;~* Use of analgesic or anti inflammatory medication (except Paracetamol) in the previous 12 hours;~* History of allergy or hypersensitivity to amoxicillin and/ or ketoprofen.~The above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.

- Gender: ALL
- Minimum Age: 4 Years
- Maximum Age: 11 Years
- Healthy Volunteers: f

Study Arms:
- Ketoprofen + Amoxicillin (Type: EXPERIMENTAL): Ketoprofen + Amoxicillin for 3 days, then Amoxicillin alone for 7 days
- Amoxicillin (Type: PLACEBO_COMPARATOR): Placebo (for ketoprofen) + Amoxicillin for 3 days, then Amoxicillin alone for 7 days

Based on this trial design, predict the completion outcome and termination type (if applicable).